Following the objective of making antigen tests more reliable in a wider time frame, Sensyne applied its AI reading device MagnifEye to draw precise and quick conclusions to the the self-test issued by Excalibur. Joint tests have seen success, paving the way for adoption in the European market, the UK included.
In lab settings, MagnifEye has already been in use by the NHS for more than a million lateral flow antigen tests. Independent research has shown that the AI significantly increased testing accuracy. Within two seconds, the AI classifies tests as “positive”, “negative”, “void” or “invalid”. The first two categories being self-explanatory, the “void” label indicates the control line cannot be detected and “invalid” meaning that the sample is corrupted or not useable for other reasons. A certain threshold of very small viral loads were especially missed by human examiners, while the AI performed better.
Non-COVID diagnostics are being pursued using the system for the future as well, while the certified COVID tests seek to secure international pandemic recovery.
The Med-Tech World conference, which follows a successful digital event in 2020, will run from 18th-19th November 2021 and will highlight innovations and developments in digital health across the globe. With so many countries realising the potential for exponential growth, Med-Tech World will address the opportunities and challenges driving this multi-million forum – embracing the potential for technological innovation to change the face of medicine in this global sector. Register your interest here!
Royal College of Surgeons and the National College of Art and Design partner to develop a silicone heart model